Cvs Health (CVS) Short term Debt (2009 - 2026)

Cvs Health (CVS) has reported Short term Debt for 18 consecutive years, with $2.0 billion the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Short term Debt fell 68.21% year-over-year to $2.0 billion; the trailing twelve-month figure through Jun 2026 stood at $2.0 billion (down 68.21% YoY), and the FY2025 full-year result was $4.1 billion, up 12.25% from the prior year.
• Short term Debt slipped to $2.0 billion in Q2 2026 per CVS's latest filing, from $2.6 billion in the prior quarter.
• Across five years, Short term Debt topped out at $6.2 billion in Q2 2025 and bottomed at $1.4 billion in Q3 2022.
• Historically, Short term Debt has averaged $3.3 billion across 5 years, with a median of $3.7 billion in 2024.
• The sharpest annual moves came in 2022 and 2026: Short term Debt jumped 6598.33% in 2022, then plunged 68.21% in 2026.
• Over 5 years, Short term Debt stood at $1.8 billion in 2022, then surged by 55.91% to $2.8 billion in 2023, then surged by 30.74% to $3.6 billion in 2024, then increased by 12.25% to $4.1 billion in 2025, then sank by 51.87% to $2.0 billion in 2026.
• According to Business Quant data, Short term Debt over the past three periods registered $2.0 billion, $2.6 billion, and $4.1 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.